Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.36
    +1.46 (+1.78%)
     
  • GOLD FUTURES

    2,339.80
    -6.60 (-0.28%)
     
  • DOW

    38,483.77
    +243.79 (+0.64%)
     
  • Bitcoin GBP

    53,603.00
    +301.75 (+0.57%)
     
  • CMC Crypto 200

    1,435.15
    +20.39 (+1.44%)
     
  • NASDAQ Composite

    15,713.67
    +262.36 (+1.70%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Further weakness as Science 37 Holdings (NASDAQ:SNCE) drops 28% this week, taking one-year losses to 88%

It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to avoid stomach churning catastrophes, wherever possible. So spare a thought for the long term shareholders of Science 37 Holdings, Inc. (NASDAQ:SNCE); the share price is down a whopping 88% in the last twelve months. That'd be enough to make even the strongest stomachs churn. Because Science 37 Holdings hasn't been listed for many years, the market is still learning about how the business performs. And the share price decline continued over the last week, dropping some 28%. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.

If the past week is anything to go by, investor sentiment for Science 37 Holdings isn't positive, so let's see if there's a mismatch between fundamentals and the share price.

View our latest analysis for Science 37 Holdings

Because Science 37 Holdings made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally expect to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

ADVERTISEMENT

Science 37 Holdings grew its revenue by 70% over the last year. That's well above most other pre-profit companies. So the hefty 88% share price crash makes us think the company has somehow offended market participants. Something weird is definitely impacting the stock price; we'd venture the company has destroyed value somehow. We'd recommend taking a very close look at the stock (and any available forecasts), before considering a purchase, because the share price is not correlated with the revenue growth, that's for sure. Of course, investors do over-react when they are stressed out, so the sell-off could be unjustifiably severe.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

If you are thinking of buying or selling Science 37 Holdings stock, you should check out this FREE detailed report on its balance sheet.

A Different Perspective

Science 37 Holdings shareholders are down 88% for the year, even worse than the market loss of 22%. There's no doubt that's a disappointment, but the stock may well have fared better in a stronger market. With the stock down 24% over the last three months, the market doesn't seem to believe that the company has solved all its problems. Basically, most investors should be wary of buying into a poor-performing stock, unless the business itself has clearly improved. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Even so, be aware that Science 37 Holdings is showing 2 warning signs in our investment analysis , you should know about...

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here